Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Interim Analysis of the Extension Study with rVIII-SingleChain in Previously Untreated Patients (PUPs) with Severe Hemophilia A (CSL627-3001)

Elena Santagostino, Kathelijn Fischer, Christoph Koenigs, MD PhD, Claudia Djambas Khayat, MD BSc, Samantha Lucas, Blanca Salazar, Andres Brainsky, MD, Thomas Chung, Brahm Goldstein, Johnny Mahlangu, MMed, FCPath

Blood (2019) 134 (Supplement_1): 162.

https://doi.org/10.1182/blood-2019-123981

Published: 2019

Journal Articles

Correlations of Plasma Cytokine Levels and Anti-FVIII Antibodies during Immune Tolerance Induction

Johannes Hartmann, MD, Anja Schmidt, PhD, Marko Beilfuss, Diana Stichel, Christine Heller, MD, Dirk Schwabe, MD, Thomas Klingebiel, MD, Nadia P Ewing, MD, Christoph Koenigs, MD PhD

Blood (2018) 132 (Supplement 1): 2471.

https://doi.org/10.1182/blood-2018-99-110588

Published: 2018

Journal Articles

99.3% of Inhibitors in Severe Hemophilia a Develop before Exposure Day 75. Time to Change Definition of Previously Treated Patients; Data from 1038 Patients with Severe Hemophilia a of the Pednet Registry

Blood (2018) 132 (Supplement 1): 2472.

https://doi.org/10.1182/blood-2018-99-114518

Published: 2018

Journal Articles

Elimination of FVIII-Specific B Cells By Immunotoxins Comprised of a Single FVIII Domain Fused to Pseudomonas Exotoxin a

Kerstin Brettschneider, Anja Schmidt, PhD, Joerg Kahle, PhD, Aleksander Orlowski, Diana Stichel, Karin Becker-Peters, Sonja Neimanis, PhD, Christine Heller, MD, Thomas Klingebiel, MD, Dirk Schwabe, MD, Christoph Koenigs, MD PhD

Blood (2016) 128 (22): 561.

https://doi.org/10.1182/blood.V128.22.561.561

Published: 2016

Journal Articles

Immunosuppressive FVIII-Specific Human Cartregs in Hemophilia a

Jeong Heon Yoon, PhD, Anja Schmidt, PhD, Yong Chan Kim, PhD, Christoph Koenigs, MD PhD, David William Scott, PhD

Blood (2015) 126 (23): 291.

https://doi.org/10.1182/blood.V126.23.291.291

Published: 2015

NARROW

Interim Analysis of the Extension Study with rVIII-SingleChain in Previously Untreated Patients (PUPs) with Severe Hemophilia A (CSL627-3001)

Correlations of Plasma Cytokine Levels and Anti-FVIII Antibodies during Immune Tolerance Induction

99.3% of Inhibitors in Severe Hemophilia a Develop before Exposure Day 75. Time to Change Definition of Previously Treated Patients; Data from 1038 Patients with Severe Hemophilia a of the Pednet Registry

Elimination of FVIII-Specific B Cells By Immunotoxins Comprised of a Single FVIII Domain Fused to Pseudomonas Exotoxin a

Immunosuppressive FVIII-Specific Human Cartregs in Hemophilia a

Email alerts

ASH Publications

American Society of Hematology

Interim Analysis of the Extension Study with rVIII-SingleChain in Previously Untreated Patients (PUPs) with Severe Hemophilia A (CSL627-3001)

Correlations of Plasma Cytokine Levels and Anti-FVIII Antibodies during Immune Tolerance Induction

99.3% of Inhibitors in Severe Hemophilia a Develop before Exposure Day 75. Time to Change Definition of Previously Treated Patients; Data from 1038 Patients with Severe Hemophilia a of the Pednet Registry

Elimination of FVIII-Specific B Cells By Immunotoxins Comprised of a Single FVIII Domain Fused to Pseudomonas Exotoxin a

Immunosuppressive FVIII-Specific Human Cartregs in Hemophilia a

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only